Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic Acid in Cardiac Surgery
NCT03639519Phase 4Unknown
- Sponsor
- El-Galaa Military Medical Complex
- Start
- Apr 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative complications and arrhythmia comparing Ascorbic acid with Placebo (2 arms). Primary endpoints: Risk of arrhythmia post operative at 7 days, Pain management at 2 days and 1 more. Status: unknown.
02
Drugs
ascorbic acid
03
Conditions
postoperative complicationsarrhythmia
Beyond the preview
Go deeper on NCT03639519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03639519.